Pfizer CEO Sold $5.6 Million Worth of Stock on Day Vaccine Announcement Sent Shares Soaring

Pfizer CEO Sold $5.6 Million Worth of Stock on Day Vaccine Announcement Sent Shares Soaring
Albert Bourla, chief executive officer of the Pfizer pharmaceutical company, at the New York Stock Exchange in New York City on Jan. 17, 2019. Drew Angerer/Getty Images
Tom Ozimek
Tom Ozimek
Reporter
|Updated:

Pfizer’s Chief Executive Officer Albert Bourla sold shares in the company worth $5.6 million on the day the drugmaker announced that its CCP virus vaccine was more than 90 percent effective, which caused Pfizer stock to surge.

Bourla sold 132,508 shares at $41.94 a share, amounting to 62 percent of his holding of Pfizer stock, according to filings with the U.S. Securities and Exchange Commission (SEC). Pfizer shares traded as high as $41.99 on Nov. 9, the day the company announced interim trial results showing its experimental vaccine for the CCP (Chinese Communist Party) virus was highly effective in preventing infection.
Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Related Topics